Your search for oral corticosteroids returned 131 results

Your search for oral corticosteroids returned 131 results

Sort Results:

Relevant Recent
News

Simponi Approved for Ulcerative Colitis

The FDA has approved Simponi (golimumab for subcutaneous injection; Janssen Biotech) to induce and maintain clinical response in adults with ulcerative colitis.
Drugs in the Pipeline

Tezepelumab Gets Breakthrough Therapy Designation for Severe Asthma

The designation was based on data from the Phase 2b PATHWAY trial that evaluated 3 doses of tezepelumab as add-on therapy in patients with a history of asthma exacerbations and uncontrolled asthma receiving inhaled corticosteroids/long-acting β-agonist with or without oral corticosteroids and additional asthma controllers vs placebo.
Drug News

FDA Panel Says No to OTC Singulair

A panel of expert advisors to the U.S. Food and Drug Administration voted overwhelmingly against moving the allergy drug Singulair from prescription to over-the-counter status.
News

Short- vs. Longer-Duration Corticosteroid Tx for COPD Exacerbations

Currently, COPD guidelines recommend that patients with acute exacerbations be treated with systemic corticosteroids for 7-14 days, however, an updated review suggests that corticosteroid treatment of a shorter duration may be as effective as conventional longer-duration therapy.